Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases

15 Jun 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28617416
DOI: 10.1038/gim.2017.56

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 casesPMID 28617416Read ↗

Bioinformatics Analysis for Circulating Cell-Free DNA in CancerSemantic proximity Read ↗

Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer TypesSemantic proximity Read ↗

Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) studySemantic proximity Read ↗

cfGWAS reveal genetic basis of cell-free DNA featuresSemantic proximity Read ↗

Baseline mutation profiling of 1134 samples of circulating cell-free DNA and blood cells from healthy individualsSemantic proximity Read ↗

Cell-free DNA from clinical testing as a resource of population genetic analysis.Semantic proximity Read ↗

Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients’ CareSemantic proximity Read ↗

cfDNAanalyzer: a comprehensive toolkit for analyzing cell-free DNA genomic sequencing data in liquid biopsySemantic proximity Read ↗

ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencingSemantic proximity Read ↗

Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings.Semantic proximity Read ↗

ACMG Secondary Findings in the Brazilian Rare Genomes Project: Insights from 5,402 genome sequencingSemantic proximity Read ↗

Low-pass whole-genome sequencing in clinical cytogenetics: a validated approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.